Back to Treatments

Treatment

Blinatumomab

1
Conditions
127
Trials
7,000
Participants
40%
Average Safety

Condition Evidence

Acute lymphoid leukemia

127 trials · 7,000 participants

85% effectiveness · 40% safety
Blinatumomab | DFDA